Orchid Pharma Limited (NSE: ORCHPHARMA)

Market Cap	75.61B
Revenue (ttm)	8.81B
Net Income (ttm)	1.12B
Shares Out	50.72M
EPS (ttm)	23.20
PE Ratio	64.27
Forward PE	47.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	182,405
Open	1,468.00
Previous Close	1,459.10
Day's Range	1,461.00 - 1,554.00
52-Week Range	432.05 - 1,590.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Orchid Pharma

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company has multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile product...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 871
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ORCHPHARMA

Financial Performance

In 2023, Orchid Pharma's revenue was 8.19 billion, an increase of 23.05% compared to the previous year's 6.66 billion. Earnings were 921.67 million, an increase of 98.99%.